Fu Y, Li L, Hao S, Guan R, Fan G, Shi C, Wan H, Chen W, Zhang H, Liu G, Wang J, Ma L, You J, Ni X, Yue Z, Xu X, Sun X, Liu X, Yuen Lee SM (2017) Draft genome sequence of the Tibetan medicinal herb Rhodiolacrenulate
Referenc e: Semaglutide significantly reduces risk of major kidney disease events, cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease, groundbreaking study reveals
A meta-analysis of the use of SGLT-2 inhibitors in hospitalized patients in 23 studies with 19,846 participants observed an increase in DKA that did not achieve statistical significance because the frequency of DKA was low (235)
Every peptide-class section above shows dose-dependent side effect rates
Onishi M, Yamano K, Sato M, Matsuda N, Okamoto K